News & Events

Part of our mandate at EXCITE International is to keep our audience up-to-date on our activities and industry news.


Explore MedTech Virtual Event: U.S. Healthcare Payer Adoption - Key to Coverage Post FDA Approval

Posted Mar 16th, 2023

This virtual event will take place on March 30th at 10am MST / 12pm EST / 1pm AST.

Read more

EXCITE International joins the FDA’s Early Payor Feedback Program

Posted Jan 26th, 2023 in News

EXCITE International, a not-for-profit collaborative focused on fixing unacceptable market adoption problems for innovative non-drug medical technologies, is pleased to announce that it has become a member of the U.S. Food and Drug Administration's (FDA) Early Payor Feedback Program (EPFP). With this membership, EXCITE becomes an additional resource for companies who wish to speak with payors, health professionals and industry experts through an Early Technology Review (ETR) in preparation f...

Read more

EXCITE International has become a member of FDA’s Early Payor Feedback Program

Posted Nov 23rd, 2022 in News

It is a great pleasure to announce that EXCITE International has become a member of the FDA’s Early Payor Feedback Program (EPFP) set up by the Center for Devices and Radiological Health (CDRH). This is a voluntary opportunity for medical device sponsors to obtain payor input on clinical trial design or other plans for gathering clinical evidence needed to support positive coverage decisions.

Read more

Leaders in Bringing Innovative Ideas to Healthcare

Posted Jun 28th, 2022 in News

EXCITE International is a not for profit collaborative focused on fixing unacceptable market adoption problems for innovative nondrug medical technologies.

Read more

Payers Advisory Committee Guidance Document

Posted Jan 31st, 2022

A priority for EXCITE International is to bring payer and health system perspectives into the early stages of developing and evaluating new technologies. The present pathway to market is disjointed in that innovators focus on regulatory requirements, only to be subsequently rejected by payers because the evidence generated for regulatory purposes fails to address the concerns of payers and health systems. There are two reasons that innovators focus on regulatory requirements. First, regulato...

Read more

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.